Citations 1
Phase 1 first-in-human study of MEDI2228, a BCMA-targeted ADC, in patients with relapsed refractory multiple myeloma
Migkou, Magdalini , Bhutani, Manisha , Kalff, Anna , Walcott, Farzana L. , Pore, Nabendu , Brown, Miranda, Wang, Fujun, Cheng, Lily , Kagiampakis, Ioannis, Williams, Marna, Wu, Yuling , Kubiak, Robert J., Zonder, Jeffrey A. , Larsen, Jeremy T. , Sirdesai, Shreerang, Kumar, Shaji , Larsen, Jeremy, Kumar, Shaji K , Dimopoulos, Meletios Α. , Ailawadhi, Sikander , Kinneer, Krista , Jiang, Yu Yan , Kubiak, Robert J., Yee, Andrew J
Leukemia & Lymphoma | October 15, 2024 | Volume: 65 | Issue: 12 | Pages: 1789-1800
